![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print June 21, 2002
J. Biol. Chem, 10.1074/jbc.M203311200
Submitted on April 6, 2002
Revised on June 18, 2002
Accepted on June 21, 2002
Department of Dermatology, Ludwig-Maximilians University, München 80337
Corresponding Author: Klaus.Degitz{at}lrz.uni-muenchen.de
Selected sequences in the DNA double helix can be specifically recognized by oligonucleotides via hydrogen bonding interactions. The resulting triple-helix can modulate DNA metabolism, and especially interfere with transcription in a gene-specific manner. To explore the potential of triplex-forming oligonucleotides (TFOs) as gene repressors, a TFO was designed to target a 16 bp sequence within the third intron of the human intercellular-adhesion molecule-1 (ICAM-1) gene, which plays a key role in initiating inflammation. TFO binding to its ICAM-1 target sequence was characterized in vitro and also demonstrated in cell nuclei with the set-up of a novel magnetic capture assay, which represents a general experimental approach to the detection of specific TFO binding and to the determination of the accessibility of a given genomic DNA locus. In a human keratinocyte cell line (A431) we observed that: i) the ICAM-1 target sequence in the chromatin context within the nuclei is still available for triplex formation and ii) TFO inhibits sequence- and gene-specifically IFN-gamma induced ICAM-1 surface expression. Collectively, the data demonstrate effective and specific inhibition of ICAM-1 expression by TFO treatment and support the view that triplex-mediated gene targeting might be a valuable technique for anti-inflammatory or anti-cancer strategies.
This article has been cited by other articles:
![]() |
G. D. Maurer, J. H. Leupold, D. M. Schewe, T. Biller, R. E. Kates, H.-M. Hornung, U. Lau-Werner, S. Post, and H. Allgayer Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1123 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sonnet, P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F. Authier, F. Chretien, R. K. Gherardi, and B. Chazaud Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems J. Cell Sci., June 15, 2006; 119(12): 2497 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Schewe, T. Biller, G. Maurer, I. A. Asangani, J. H. Leupold, E. R. Lengyel, S. Post, and H. Allgayer Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2{alpha}-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers Clin. Cancer Res., December 15, 2005; 11(24): 8538 - 8548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Uil, H. J. Haisma, and M. G. Rots Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities Nucleic Acids Res., November 1, 2003; 31(21): 6064 - 6078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cassidy, N. Puri, and P. S. Miller Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides Nucleic Acids Res., July 15, 2003; 31(14): 4099 - 4108. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |